Home/Filings/8-K/0001193125-26-009812
8-K//Current report

Galecto, Inc. 8-K

Accession 0001193125-26-009812

$GLTOCIK 0001800315operating

Filed

Jan 11, 7:00 PM ET

Accepted

Jan 12, 8:00 AM ET

Size

16.3 MB

Accession

0001193125-26-009812

Research Summary

AI-generated summary of this filing

Updated

Galecto, Inc. Announces Presentation at J.P. Morgan Healthcare Conference

What Happened
Galecto, Inc. (GLTO) filed a Current Report on Form 8-K on January 12, 2026 (Item 7.01) disclosing that it intends to hold meetings with securities analysts, investors and others in connection with the 44th Annual J.P. Morgan Healthcare Conference beginning January 12, 2026. The company disclosed it will use a corporate slide presentation during these meetings and furnished that presentation as Exhibit 99.1 to the 8-K.

Key Details

  • Filing date: January 12, 2026; disclosure made under Item 7.01 (Regulation FD Disclosure).
  • Event: 44th Annual J.P. Morgan Healthcare Conference, meetings beginning January 12, 2026.
  • Exhibit furnished: Corporate Presentation (January 2026) filed as Exhibit 99.1.
  • Form also includes Exhibit 104 (cover page interactive XBRL) per Item 9.01.

Why It Matters
This 8-K signals Galecto’s investor outreach at a major healthcare conference where management often provides program updates, strategic context or clinical progress. The posted slide deck (Exhibit 99.1) is available to investors and may contain the company’s latest presentation materials; because the disclosure is made under Regulation FD, material information shared in these meetings should be broadly available to the public. This filing is a disclosure of forthcoming presentations, not an earnings or financial-results release.

Issuer

Galecto, Inc.

CIK 0001800315

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001800315

Filing Metadata

Form type
8-K
Filed
Jan 11, 7:00 PM ET
Accepted
Jan 12, 8:00 AM ET
Size
16.3 MB